CVS bullish trajectory for possible weekend gap jump
396
CVS fundamentals are impeccable: P/B 1.48, P/E 12, Div/Yield 2.68%, Q3 revenue 67B, 2020 earnings guidance $7.35-7.45 per share. CVS is the largest pharmacy in the US. 70% percent of the US population lives within three minutes of a CVS store. CVS fair value is $92 updated on November 20 by Morningstar. I entered CVS$73-75strangle12/11 contracts at 3:30pm on 12/4 to have insurance on the low end *just in case. 75call Delta: .44, Theta: .09, 73put Delta: .30, Theta: .07. From the look of it, CVS checks all the boxes: technically, fundamentally & newsworthy are all bullish for CVS. (Bloomberg) CVS Health will administer Eli Lilly's Covid-19 treatment in patients homes and in long-term care facilities through a program with the U.S. government’s Operation Warp Speed, the pharmacy chain said. Lilly’s monoclonal antibody therapy, bamlanivimab, has been found to keep patients in the early stages of Covid-19 from developing more severe disease that requires hospitalization. Do your own due diligence, your risk is 100% your responsibility. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Small incremental steps work : If you double a penny for a month it = $5,368,709. Good luck and happy trading friends...
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.